Investor's Business Daily | Stock News & Stock Market Analysis - IBD

No preparation and rapid control make all the difference. To meet customer demand and support new product development, Cresilon plans to expand both in terms of staff and facilities—a current expansion in Brooklyn is underway to serve large-scale manufacturing needs.

About us Recognizing the importance of managing a traumatic bleed quickly and effectively, Joe Landolina and Isaac Miller founded Cresilon, Inc. Cresilon has since grown into a medical device company headquartered in Brooklyn, New York, and Joe is now gearing up to take his technology to the veterinary market— making an impact in animal health.

Get in touch Join our team. Stops bleeding in seconds.

Plant-based gel technology that accelerates hemostasis. Hemostatic solution that supports the natural clotting process Easy application when rapid hemorrhage control is needed.

Easy to apply, easy to remove No preparation and rapid control make all the difference. Expanding locally To meet customer demand and support new product development, Cresilon plans to expand both in terms of staff and facilities—a current expansion in Brooklyn is underway to serve large-scale manufacturing needs.

Applications for our summer internship program are open!